| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
Departments of 1 Molecular Biology and 2 Department of Neurosciences, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio and 3 Department of Pathology, New York University School of Medicine, New York, New York
Requests for reprints: George R. Stark, Department of Molecular Biology, New York University School of Medicine, New York, NY. Phone: 216-444-3900; Fax: 216-444-3279; E-mail: starkg{at}ccf.org.
Signal transducer and activator of transcription 3 (STAT3) is phosphorylated on tyrosine residue 705 in response to growth factors or cytokines to form activated homodimers that drive gene expression. Because the stat3 promoter has a binding site for STAT3 dimers, the amount of STAT3 protein increases when STAT3 is activated (e.g., in response to interleukin 6). Unphosphorylated STAT1 is known to drive the expression of certain genes. To explore the possibility of a similar role for the induced expression of unphosphorylated STAT3, we overexpressed either Y705F STAT3, which can not be phosphorylated on residue 705, or wild-type STAT3 in normal human mammary epithelial cells or STAT3-null mouse cells. The levels of many mRNAs were affected strongly by high levels of either form of STAT3. Some genes whose expression was increased by overexpressed STAT3, but not by activated STAT3 dimers, encode well-known oncoproteins (e.g., MRAS and MET). In many tumors, STAT3 is activated constitutively, and thus the unphosphorylated form is likely to be expressed highly, driving oncogene expression by a novel mechanism. In addition, expression of the stat3 gene is increased strongly in response to interleukin 6, and the high levels of unphosphorylated STAT3 that result drive a substantial late phase of gene expression in response to this cytokine. Thus, unphosphorylated STAT3, which activates gene expression by a novel mechanism distinct from that used by STAT3 dimers, is very likely to be an important transcription factor both in cancer and in responses to cytokines.
Key Words: expression analysis • tumor arrays • immunohistochemistry • MRAS • RANTES
This article has been cited by other articles:
|
|
 |
|
  S.-H. Tan and M. T Nevalainen Signal transducer and activator of transcription 5A/B in prostate and breast cancers Endocr. Relat. Cancer, June 1, 2008; 15(2): 367 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-P. Kung and N. Raab-Traub Epstein-Barr Virus Latent Membrane Protein 1 Induces Expression of the Epidermal Growth Factor Receptor through Effects on Bcl-3 and STAT3 J. Virol., June 1, 2008; 82(11): 5486 - 5493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. T. Lam, G. Wright, R. E. Davis, G. Lenz, P. Farinha, L. Dang, J. W. Chan, A. Rosenwald, R. D. Gascoyne, and L. M. Staudt Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma Blood, April 1, 2008; 111(7): 3701 - 3713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kiryu-Seo, R. Kato, T. Ogawa, S. Nakagomi, K. Nagata, and H. Kiyama Neuronal Injury-inducible Gene Is Synergistically Regulated by ATF3, c-Jun, and STAT3 through the Interaction with Sp1 in Damaged Neurons J. Biol. Chem., March 14, 2008; 283(11): 6988 - 6996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Seethala, W. E. Gooding, P. N. Handler, B. Collins, Q. Zhang, J. M. Siegfried, and J. R. Grandis Immunohistochemical Analysis of Phosphotyrosine Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor Autocrine Signaling Pathways in Head and Neck Cancers and Metastatic Lymph Nodes Clin. Cancer Res., March 1, 2008; 14(5): 1303 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mukhopadhyay, M. Shah, F. Xu, K. Patel, R. M. Tuder, and P. B. Sehgal Cytoplasmic provenance of STAT3 and PY-STAT3 in the endolysosomal compartments in pulmonary arterial endothelial and smooth muscle cells: implications in pulmonary arterial hypertension Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L449 - L468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Iyer and N. C. Reich Constitutive nuclear import of latent and activated STAT5a by its coiled coil domain FASEB J, February 1, 2008; 22(2): 391 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, L. Gao, Y. Li, G. Lin, Y. Shao, K. Ji, H. Yu, J. Hu, D. V. Kalvakolanu, D. J. Kopecko, et al. Effects of Plasmid-Based Stat3-Specific Short Hairpin RNA and GRIM-19 on PC-3M Tumor Cell Growth Clin. Cancer Res., January 15, 2008; 14(2): 559 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-J. Hsieh, H. Wakiyama, S. Levitsky, and J. D. McCully Cardioplegia and Diazoxide Modulate STAT3 Activation and DNA Binding Ann. Thorac. Surg., October 1, 2007; 84(4): 1272 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Germain and D. A. Frank Targeting the Cytoplasmic and Nuclear Functions of Signal Transducers and Activators of Transcription 3 for Cancer Therapy Clin. Cancer Res., October 1, 2007; 13(19): 5665 - 5669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Xu, S. Mukhopadhyay, and P. B. Sehgal Live cell imaging of interleukin-6-induced targeting of "transcription factor" STAT3 to sequestering endosomes in the cytoplasm Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1374 - C1382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kalakonda, S. C. Nallar, P. Gong, D. J. Lindner, S. E. Goldblum, S. P. Reddy, and D. V. Kalvakolanu Tumor Suppressive Protein Gene Associated with Retinoid-Interferon-Induced Mortality (GRIM)-19 Inhibits src-Induced Oncogenic Transformation at Multiple Levels Am. J. Pathol., October 1, 2007; 171(4): 1352 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schindler, D. E. Levy, and T. Decker JAK-STAT Signaling: From Interferons to Cytokines J. Biol. Chem., July 13, 2007; 282(28): 20059 - 20063. [Full Text] [PDF]
|
|
|
|
 |
|
 J. McLaren, M. Rowe, and P. Brennan Epstein-Barr virus induces a distinct form of DNA-bound STAT1 compared with that found in interferon-stimulated B lymphocytes J. Gen. Virol., July 1, 2007; 88(7): 1876 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kalakonda, S. C. Nallar, D. J. Lindner, J. Hu, S. P. Reddy, and D. V. Kalvakolanu Tumor-Suppressive Activity of the Cell Death Activator GRIM-19 on a Constitutively Active Signal Transducer and Activator of Transcription 3 Cancer Res., July 1, 2007; 67(13): 6212 - 6220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vaclavicek, J. L. Bermejo, R. K Schmutzler, C. Sutter, B. Wappenschmidt, A. Meindl, M. Kiechle, N. Arnold, B. H F Weber, D. Niederacher, et al. Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer Endocr. Relat. Cancer, June 1, 2007; 14(2): 267 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yang, X. Liao, M. K. Agarwal, L. Barnes, P. E. Auron, and G. R. Stark Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NF{kappa}B Genes & Dev., June 1, 2007; 21(11): 1396 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wang, H. D. Edington, U. N.M. Rao, D. M. Jukic, S. R. Land, S. Ferrone, and J. M. Kirkwood Modulation of Signal Transducers and Activators of Transcription 1 and 3 Signaling in Melanoma by High-Dose IFN{alpha}2b Clin. Cancer Res., March 1, 2007; 13(5): 1523 - 1531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lassmann, I. Schuster, A. Walch, H. Gobel, U. Jutting, F. Makowiec, U. Hopt, and M. Werner STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation J. Clin. Pathol., February 1, 2007; 60(2): 173 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Kim, R. W. Mutter, C. Cao, J. M. Albert, E. T. Shinohara, K. R. Sekhar, and B. Lu Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of Survivin following irradiation. Mol. Cancer Ther., November 1, 2006; 5(11): 2659 - 2665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ishii, A. Pirkmaier, J. V. Alvarez, D. A. Frank, I. Keselman, D. Logothetis, J. Mandeli, M. J. O'Connell, S. Waxman, and D. Germain Cyclin d1 overexpression and response to bortezomib treatment in a breast cancer model. J Natl Cancer Inst, September 6, 2006; 98(17): 1238 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Gao and J. F. Bromberg Touched and Moved by STAT3 Sci. Signal., July 11, 2006; 2006(343): pe30 - pe30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Levy and G. Inghirami STAT3: A multifaceted oncogene PNAS, July 5, 2006; 103(27): 10151 - 10152. [Full Text] [PDF]
|
|
|
|
|
|
J. W. Darnowski, F. A. Goulette, Y.-j. Guan, D. Chatterjee, Z.-F. Yang, L. P. Cousens, and Y. E. Chin Stat3 Cleavage by Caspases: IMPACT ON FULL-LENGTH Stat3 EXPRESSION, FRAGMENT FORMATION, AND TRANSCRIPTIONAL ACTIVITY J. Biol. Chem., June 30, 2006; 281(26): 17707 - 17717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Ho and L. B. Ivashkiv Role of STAT3 in Type I Interferon Responses: NEGATIVE REGULATION OF STAT1-DEPENDENT INFLAMMATORY GENE ACTIVATION J. Biol. Chem., May 19, 2006; 281(20): 14111 - 14118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lu, W. Ouyang, and C. Huang Inflammation, a Key Event in Cancer Development Mol. Cancer Res., April 1, 2006; 4(4): 221 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Liu, K. M. McBride, and N. C. Reich STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-{alpha}3 PNAS, June 7, 2005; 102(23): 8150 - 8155. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
